Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)

NAActive, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2027

Conditions
Fibroid UterusSarcoma Uterus
Interventions
PROCEDURE

Echo-guided uterine biopsy

"Echo-guided uterine biopsy will be performed by a specialized radiologist by transvaginal and exclusive transuterine approach. 4 to 5 samples will be made.~Local anesthesia will be performed. A pain assessment will be performed during the biopsy (visual or verbal scale)."

Trial Locations (1)

33076

Institut Bergonié, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

GIRCI SOHO

OTHER

lead

Institut Bergonié

OTHER

NCT04250766 - Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR) | Biotech Hunter | Biotech Hunter